Strides, Shasun Pair To Rebuild Fortunes Via Mutual Strengths
This article was originally published in PharmAsia News
Executive Summary
Strides and Shasun have seen an opportunity to grow as a single combined unit. The match is a no-brainer – Strides needs scale to make a global splash after selling Agila last year, while Shasun requires management bandwidth to pull it out of sagging prospects in APIs and CRAMS.